论文部分内容阅读
诺华疫苗公司对于侵袭性脑膜炎球菌病的预防有长期的研发兴趣。单价脑膜炎球菌C群多糖结合疫苗Menjugate,是其最初取得生产许可的疫苗,系由在英国出现的一种致命的C群ST-11菌株研制而成的疫苗。而四价脑膜炎球菌ACWY多糖结合疫苗Menveo是其最近研发和取得生产许可的疫苗。
Novartis Vaccine has a long-standing interest in the prevention of invasive meningococcal disease. The monovalent meningococcal C polysaccharide conjugate vaccine, Menjugate, was initially licensed for its manufacture as a vaccine derived from a deadly C group ST-11 strain in the United Kingdom. The meningococcal meningococcal ACWY polysaccharide conjugate vaccine Menveo is a vaccine that has recently been developed and licensed for production.